Investigator-Sponsored Research
Frequently Asked Questions

Investigator-Sponsored Research Program

The Investigator-Sponsored Research (ISR) Program represents an important portion of medical research. The ISR Program serves as a conduit between Boston Scientific and external researchers to expand research.

Boston Scientific provides support for research that advances medical and scientific knowledge about our products and that generates medical interventions. This global program is open to all qualified researchers who are interested in conducting their own research


After reading the Submission Process, log-in to submit or edit your proposal


If you still have questions after reading over the Frequently Asked Questions (FAQs), please reach out to us

Research Areas

Each Boston Scientific division reviews research requests for a variety of topics pertaining to Boston Scientific products and associated disease states.

We are currently looking at research in the following areas:

Cardiovascular Topics of Interest

  • New/emerging Technologies
  • New/extended applications of DES
  • Role of DES in extended patient groups
  • Health Economics and/or Quality of Life
  • Comparative-Effectiveness
  • Geographic variation in device use
  • Valvular disease
Back to top

Rhythm & Electrophysiology Topics of Interest

  • Cardiac mapping
  • Cardiac ablation
  • Subcutaneous ICD
  • Heart failure
  • Left atrial appendage closure
Back to top

Endoscopy/Pulmonary Topics of Interest

  • Gastro
  • Biliary
  • Snares
  • polypectomy
  • Severe asthma and bronchial thermoplasty (BT)
    • BT – patient selection and markers of response and/or safety.
    • Severe asthma – natural history.
  • Bronchial thermoplasty in practice
    • Case studies demonstrating safety and efficacy of BT.
    • Procedure optimization.
    • Clinical experience in patients with characteristics such as:
      • Low FEV1
      • Elderly
      • Occupational asthma
      • Allergic and non-allergic asthma
      • Asthma with concomitant use of immunomodulatory agents
      • Asthma with a COPD component.
    • Patient satisfaction data.
    • Clinical outcome data such as impact on medication usage.
  • Bronchial thermoplasty mechanism of action
    • Evaluate the impact of BT on airway remodeling, inflammation, and hyperresponsiveness.
    • Assess impact on asthma pathophysiology.
    • Identification of biomarkers for patient responders
    • Further definition of patient responders. 
Back to top

Urology and Pelvic Health Topics of Interest

  • Upper Tract Stone Disease
    • Optimal laser settings for dusting vs. fragmentation and associated stone free rates
    • Endoscope – flexible ureteroscope - economics – single use versus reusable (repair costs, deterioration of performance, safety, etc.)
    • Stent encrustation (causes, effects on patients, economic impact, patient and economic costs of forgotten indwelling stents)
    • Ureteral stent pain 
  • BPH
    • Use of GreenLight XPS™ PVP Laser System in men with prostate volume > 80 grams
    • Use of GreenLight XPS PVP Laser System in men that are high risk surgical candidates i.e. anticoagulated
    • Comparison of GreenLight XPS PVP Laser System with other surgical modalities for BPH (Plasma Button, HoLep, Thulium) 
    • Economic data regarding the health system costs of Green Light XPS Laser System compared to other treatments for BPH
  • Female Stress Urinary Incontinence
    • The case for minislings as standard of care therapy for stress urinary incontinence: Solyx™ SIS System versus TVT™ Retropubic System
    • White paper on requirements for moving minislings into the office: clinical and re-imbursement perspectives 
  • Abnormal Uterine Bleeding
    • Comparisons of different treatment modalities on patient outcomes and post-procedural complications (i.e. pain)
    • Assess impact of vasopressin and mean arterial pressure on fluid management 
  • Removal of Uterine Tissue (Fibroids, Polyps)
    • Data on efficacy and safety
    • Comparative studies with currently available technologies
    • Data on the cost effectiveness of Symphion™ Tissue Removal System for polyps and fibroids 
  • Male Stress Urinary Incontinence
    • Predictors of urethral atrophy after AUS placement
    • Long-term outcomes for AUS placement after pelvic XRT
    • Validation of a questionnaire to assess the severity of male SUI to show correlation to treatment options
  • Male Erectile Dysfunction
    • Patient satisfaction in men receiving an IPP for ED (flaccid state, rigidity, penile girth)
    • Cost effectiveness of IPP as first line therapy in men with ED and a poor prognosis for the success of conservative therapies
Back to top

Neuromodulation Topics of Interest

  • Spinal Cord Stimulation
    • Treatment of chronic, intractable pain of the back and legs using the Spectra WaveWriter™ SCS System
      • Of particular interest:
        • Efficacy of combination therapy
        • Programming optimization
        • Contour™ field shaping algorithm vs other field shapes
        • Anatomical vs paresthesia-based neural targeting
  • Deep Brain Stimulation
    • Treatment of Parkinson’s Disease and other movement disorders using Vercise™ Deep Brain Stimulation System
      • Of particular interest:
        • Freezing of gait
        • Replacement of other DBS systems with Vercise DBS System
        • Use of multiple frequencies on one lead
        • Use of current fractionalization to maximize overlap with desired structures and minimize stimulation of non-target tissue
        • Novel targets for Parkinson’s Disease, Dystonia, Tremor (may require IDE)

Back to top

How the U.S. Physician Payment Sunshine Act Impacts Sponsored Researchers

The U.S. Physician Payment Sunshine Act requires all pharmaceutical, biologic and medical device manufacturers – like Boston Scientific – to report annually to the U.S. government payments and transfers of value made to U.S. physicians and teaching hospitals. This could include educational and research grants and charitable donations. 

Read additional details about the U.S. Physician Payment Sunshine Act